EMA Seeks Industry Feedback on Single-Arm Trial Guidance
May 31, 2023
The European Medicines Agency (EMA) is seeking industry’s thoughts on a new draft guidance on general considerations and challenges for single-arm trials that serve as the key source of efficacy data.